The partnering company is Cooper Pharma, a leading Moroccan pharmaceutical company with presence in Africa and Middle East. Daewoong Pharmaceutical’s Fexuprazan takes its first step into Africa Entering into a partnership with Cooper Pharma, the No. By entering into this Agreement, Daewoong Pharmaceutical plans to expand its presence of P-CAB drug Fexuprazan in the African pharmaceutical market for gastroesophageal reflux disease (GERD). Forward-Looking StatementsThis press release contains forward-looking statements that are based on the current beliefs and expectations of Daewoong Pharmaceutical's management. The results of early clinical trials may not be indicative of the results of later-stage or larger-scale clinical trials.

Source: The North Africa Journal July 24, 2023 05:02 UTC